GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Cash From Discontinued Investing Activities

Bharat Immunologicals & Biologicals (BOM:524663) Cash From Discontinued Investing Activities : ₹0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Bharat Immunologicals & Biologicals's cash from discontinued investing activities for the three months ended in Sep. 2023 was ₹0.00 Mil. It means Bharat Immunologicals & Biologicals received ₹0.00 Mil from discontinued investing activities. Bharat Immunologicals & Biologicals's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.00 Mil.


Bharat Immunologicals & Biologicals Cash From Discontinued Investing Activities Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals Cash From Discontinued Investing Activities Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash From Discontinued Investing Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash From Discontinued Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bharat Immunologicals & Biologicals Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bharat Immunologicals & Biologicals Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines